Reply is the place to meet an incredible variety of enthusiastic, passionate, ideas-driven people, who want to make a difference and an impact.Would you like to know more?
Fresenius Medical Care, the world’s largest provider of products and services for patients with chronic kidney failure, aimed to launch the first worldwide platform for dialysis patients, their families, healthcare professionals as well as investors. Improved presentation and target-group specific content were used to optimise the brand experience.
Triplesense Reply developed the concept for the service portal, which presents emotional stories and facts on dialysis. The project launch was supported by a usability test together with the Centre of Kidney Diseases and High-blood-pressure Illnesses (Centrum für Nieren- und Hochdruckkrankheiten; CfNH) in Frankfurt am Main and test individuals in Asia and the USA via remote. The customer journey was customised to the target groups medical professionals, patients and their families, investors, potential employees and the press. The platform is divided into two areas: emotional stories and facts. Users can choose between these two perspectives according to their interests. As a result, there are personal points of entry for target groups and individual customer journeys. A creative combination of sticky navigation and off-canvas menus support the user experience technically – regardless of the end-user device.
The dialysis portal informs patients in detail about treatment options and therapies. Patients can find a suitable dialysis centre anywhere in the world on the website. For medical professionals, the platform offers access to detailed and graphically illustrated information on products and services, which is supplemented by relevant study results. Investors have convenient access to the most important news, events, interactive charts and tools with real-time data. The website design impresses through emotionality, generosity and user-friendliness.
Triplesense Reply planned, designed and implemented the new service portal on the subject of dialysis. The portal allows Fresenius Medical Care to offer customised content and to relate emotional stories that will touch every target group worldwide. At the same time, the corporation is specifically placing its competency in the area of dialysis at the disposal of patients. The website thus helps to improve the lives of dialysis patients and represents a benchmark for competitors. The portal, which is geared towards specific regional needs, is currently being launched in Europe, the USA and Asia-Pacific. An international roll-out for all Fresenius Medical Care markets is planned.
Storytelling portals by Fresenius Medical Care according to region:Global: www.freseniusmedicalcare.com USA: www.freseniusmedicalcare.us Asia-Pacific: www.freseniusmedicalcare.asia
Fresenius Medical Care is the leading provider of products and services for people with chronic kidney failure around the world. Of this group of people, more than 2.6 million are patients who regularly undergo dialysis treatment. Fresenius Medical Care treats 286,312 dialysis patients in a network of 3,361 dialysis clinics in North America, Europe, Latin America, Asia and Africa. Furthermore, Fresenius Medical Care is the worldwide leading supplier of dialysis products, such as haemodialysis equipment, dialysers and single-use products connected to dialysis care. Fresenius Medical Care is listed on the Frankfurt Stock Exchange (FME) and on the New York Stock Exchange (FMS). www.freseniusmedicalcare.com